ARRHYTHMOGENIC CARDIOMYOPATHY
Clinical trials for ARRHYTHMOGENIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new ARRHYTHMOGENIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for ARRHYTHMOGENIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug tame a rare heart rhythm disorder?
Disease control Recruiting nowThis study tests a drug called tideglusib in 120 people with a genetic heart condition that can cause dangerous heart rhythms. The drug aims to reduce abnormal heartbeats and improve heart function. Participants will take either tideglusib or a placebo daily for about a year to s…
Matched conditions: ARRHYTHMOGENIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New heart MRI study could simplify diagnosis without dye
Knowledge-focused Recruiting nowThis study will use cardiac MRI scans to measure heart tissue in 2000 people with various heart conditions, such as heart attacks, cardiomyopathies, and myocarditis. The goal is to create a reference map of normal and abnormal tissue values, which may help doctors diagnose diseas…
Matched conditions: ARRHYTHMOGENIC CARDIOMYOPATHY
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC